Bristol-Myers Science and Technology Group VP-Administration Bradley Simmons appointed to new position of president of the Bristol-Myers/Genetic Systems/Syntex cooperative cancer research partnership. Oncogen will continue under the scientific direction of George Todaro, MD . . . .
You may also be interested in...
DJO Global will acquire Trilliant Surgical, furthering its expansion into the US foot and ankle market.
Ying Huang was named CEO as his predecessor came under investigation in China and as partner Janssen was getting closer to seeking US FDA approval for its lead CAR-T therapy.
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.